Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (“WBA”) (NASDAQ: WBA) common stock between October 14, 2021 and June 26, 2024, inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants touted the WBA’s projected revenue outlook and anticipated growth while minimizing risk from seasonality and macroeconomic fluctuations. In truth, however, the complaint alleges that WBA’s optimistic reports of growth, cost cutting measures, and overall stability of its pharmacy division were misleading and that WBA’s pharmacy division was not equipped to handle the ongoing challenges in its industry and, further, would require significant restructuring to create a sustainable model.
Current Status of Case:
On February 18, 2025, Defendants filed a Motion to Dismiss the Amended Complaint. This action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.